Call again for LAZ, buy dip today and will see $1-2 profit in a very short term. Look at yesterday and today's volume, very thin. This suggest those institution or big guy are holding the shares tight, the down from $26 to $25.2 is purely due to small traders' activities. The mean target $26.7 to $27 by three big banks analysts. If you are interesting in $1 or 2 bulls profit with very low risk, now it is time to buy LAZ and hold for one or two weeks.
Not out news: Accenture wins 3-year HR outsourcing contract from Sandvik From Nordic Business Report, Sept 12, 2005 The international IT, management and outsourcing group Accenture said on Monday (12 September) that it had secured a three-year outsourcing contract from the Swedish high-tech industrial group Sandvik. The agreement covers parts of Sandvik's administrative human resources functions. LAZARD related news: NEW YORK (MarketWatch) The Medford, Ore. gourmet food products retailer plans to trade on the New York Stock Exchange under the ticker symbol "HND." Wasserstein, an independent private equity and investment firm, is an equity sponsor of the deal. Lazard CEO Bruce Wassterstein is a board member.
MM's typical play: ACN. With two big contracts this week, the stock down 50 cents? Interesting. Typical MM bashed and flush shares in order to absorb heavily at the low price. Exactly the same pattern as NGPS when MM bashed it to $14 and then Fidelity bought tons of it at $14. Interesting MM's play. From weekly chart, ACN head to $30. Good time to enter when ACN is still low.
Three contracts in a week, amazing. ACN will see rebounce. Start from monday, MM bashed ACN in order to absorb at low. But with three big contracts this week, MM hard to to that. ACN target $30. Agfa-Gevaert, Accenture in conract to supply UK digital radiology equipment 100 words 14 September 2005 01:57 am AFX International Focus English Copyright AFX News, 2005 All reproduction and presentation rights reserved. BRUSSELS (AFX) - Agfa-Gevaert NV said it has entered into an agreement with Accenture to supply digital radiology imaging equipment to hospitals in the North East of England.
My call two weeks ago: RHAT, MOT, ACN Today, a good entry for FLEX with correction after rally early this week. S&P report hold a BUY sentiment with target $16. At the same time First Call mean target $16.1 with upper limit $20 and lower side $13. Now FLEX is undervalued based on its earning discount model. FLEX rank 5 (highest undervalued) by S&P. My target still hold $16. It had several huge buy order just now, check the intraday trading, it has 250000 shares bought 5 minutes ago. LAZ definately a good buy here with its 3Q good earning coming next month. This week LAZ envolved two big M&A deals in European market. Will see above $26 again soon.
FLEX MM absorbing ACN nice move here, remember i said that MM bashed it at the beginning of this week in order to absorb it at low price. Typical MM action, however, three big contracts this week won't let MM to bash it. Now ACN head to a higher price. Same story for FLEX here, only difference is FLEX does not have solid contracts or big good news. MM bashed it for a lot time. Their mean target is $16 for FLEX by the end of 2005. If you are MM what do you want to do before you buy? If you still not holding FLEX, it is a golden opportunity to absorb it at lower than $13 level.
Three Picks In Information Technology by UBS. UBS said it favors information-technology companies with exposure to discretionary spending. "We continue to believe consulting [and] systems integration spending trends are ahead of investor sentiment," UBS said. The research firm's top picks in the IT sector are Accenture (nyse: ACN - news - people ), BearingPoint (nyse: BE - news - people ) and Cognizant Technology Solutions (nasdaq: CTSH - news - people ). UBS said it also remains positive on Sapient (nasdaq: SAPE - news - people ). Outsourcing remains a steady grower, according to UBS. "We believe modestly improving processing trends are already reflected in most stocks, and we see the government IT stocks as fairly valued," the research firm said. ACN Target $30 short term. Last week we saw $26.5 already. http://www.forbes.com/markets/2005/...ogy-picks-0919markets19.html?partner=yahootix
Out half RHAT here, reenter < @$14 one month ago, I call it here when it was $14.5. Holding my MOT and VRX, both solid company. MOT's RAZR is very popular in the market, just like IPOT NANO. VRX my target rang $23-$25. FLEX formed a double bottom recently with large volume, from TA analysis, it is a good entry point. FLEX with NORTEL deal will generate 2Billion revenue by 2006. http://yahoo.reuters.com/financeQuo...tfh10430_2005-09-19_17-21-21_n19647502_newsml LAZ I will hold it above $27. Definately a solid company utilize the M&A booming business. ACN not need to mention it again, target$30, called it here @23.6
FLEX targets of $17 and $36 by the research firm. The research firm's top EMS sector picks, rated at "buy," are Flextronics International (nasdaq: FLEX - news - people ) and Benchmark Electronics, with respective price targets of $17 and $36. Its least favorite pick is Solectron (nyse: SLR - news - people ), rated at "neutral" with a $4 price target. http://www.forbes.com/markets/2005/...onductors-0921markets09.html?partner=yahootix Dongbu Selects Accenture to Implement New Financial Management System SEOUL, South Korea - (BUSINESS WIRE) - Sept. 21, 2005 - Accenture (NYSE: ACN) has been selected to help Dongbu Insurance, Korea's second-largest non-life insurer, enhance its accounting and financial management operation to improve operational efficiencies and increase financial data transparency. It is a good time to buy today as the market in big red.